Bipartisan House Passes Pediatric Cancer Bill

Teenage Cancer Patient’s Final Fight Becomes Law as House Passes Landmark Pediatric Bill

A young girl’s determination to help others facing cancer has now become part of U.S. law. Mikaela Naylon, who died at age 16 after a five-year battle with osteosarcoma, is being honored through landmark bipartisan legislation aimed at giving pediatric cancer patients better access to life-saving treatments.

A Legacy Forged in Advocacy

Even while enduring chemotherapy and radiation, Mikaela spent her remaining years advocating for children battling rare and deadly cancers. She traveled to Washington, D.C., meeting with lawmakers and urging action to ensure that children had a fair chance at survival. Rep. Michael McCaul of Texas, who helped lead the legislation, described her and other childhood cancer patients as “the best advocates,” saying their courage inspired lawmakers to act.

What the Bill Does

Named the Mikaela Naylon Give Kids A Chance Act, the bill expands access to existing cancer therapy trials for pediatric patients and incentivizes the development of treatments specifically designed for children. The legislation reauthorizes funding for the National Institutes of Health to support pediatric disease research through fiscal year 2027 and extends the Food and Drug Administration’s authority to fast-track certain pediatric drug approvals.

These provisions aim to address a long-standing gap in cancer research, where treatments for adults often do not translate safely or effectively for children.

Bipartisan Support and a Family’s Pride

The bill passed the House unanimously, drawing support from Republicans and Democrats alike. Mikaela’s family was present as lawmakers spoke in favor of the measure, honoring her courage and determination. Her parents and brother said Mikaela lived with “hope, purpose, and a fierce determination to make the world better for the kids who would come after her.”

The Bottom Line

While Mikaela’s life was heartbreakingly short, her impact will be lasting. Through this law, her voice—and the voices of countless children like her—will continue shaping pediatric cancer care for years to come.